Life Sciences

Octane

health

Kingston Life Sciences

Kingston is a leader in life sciences innovation, offering a dynamic ecosystem where businesses can thrive. The city is home to a thriving network of start-ups, private research companies, multinational corporations, and entrepreneurs striving to revolutionize medical technology, digital health, advanced cell and gene therapy, and biopharmaceutical research. Our future-focused innovation hubs provide globally relevant health solutions for public and private sector businesses alike.

Why Kingston?

Kingston’s life sciences sector is tailored to support the growth of companies and technologies, with some key areas:

// Regenerative medicine
// Medical devices and consumables
// Pharmaceuticals
// Genomics
// Health informatics

By leveraging world-class infrastructure and expertise, Kingston empowers businesses to turn innovative solutions into real-world applications, driving advancements across the industry.

A Skilled Workforce and Collaborative Ecosystem

The city’s skilled workforce is bolstered by strong program completions in health professions, biological sciences, engineering, chemistry, and business. Coupled with thriving industries in healthcare, public administration, and education, Kingston has become a premier hub for life sciences innovation.
Leading companies such as Kinarm, Lonza, Octane, and Novari Health have chosen Kingston for their R&D and production facilities, benefiting from partnerships with St. Lawrence College, Queen’s University, and the Royal Military College. These collaborations provide access to cutting-edge facilities and expertise.

Advancing Healthcare

Centers of excellence such as the Translational Institute for Medicine, Kingston Health Sciences Centre, and Canadian Cancer Trials Group lead groundbreaking work in genomic sequencing, oncology, and advanced computing. Together, they deliver cutting-edge research and personalized healthcare solutions.

Strategic Location for Growth

With expanding biomanufacturing and wet lab capacities, Kingston offers life sciences businesses unparalleled opportunities for growth, partnerships, and long-term success. The city invites innovators to join this thriving community and contribute to its transformative impact on global health and innovation.

Through Regenerative Medicine

Kingston’s regenerative medicine sector is driving healthcare transformation with advancements in tissue repair, cell and gene therapy, and pharmaceutical development. Industry leaders like Lonza and Octane play a pivotal role in this space.

There are two main hospital sites in Kingston. Providence Care and Kingston Health Sciences Centre (KHSC). Providence Care is the region’s leading provider of specialized mental health care, rehabilitation, geriatric services, complex continuing care, palliative care, and long-term care. KHSC is southeastern Ontario’s complex, acute and specialty care, research and teaching hospital. As well the Cancer Centre of Southeastern Ontario, the Human Mobility Research Centre, and the Canadian Institute for Military and Veteran Health Research.

“When companies are looking for location, they need to look at supports that exist, and Kingston is exceptional”

health-innovation

Meet some of Kingston’s Life Science Companies

elentra

kinarm

lonza

novari

OPTT

R&D HIGHLIGHTS

CCTG

Canadian Cancer Trials Group – Queen’s Cancer Research Institute is Canada’s only integrated cancer research centre where bench researchers (Cancer Biology and Genetics), clinical trials experts (Canadian Cancer Trials Group), and population/health services researchers (Cancer Care and Epidemiology), work together under one roof.

CIMVHR

Canadian Institute for Military & Veteran Health Research as built a network of 46 Canadian universities who have agreed to work together to address the health research requirements of the Canadian military, Veterans and their families. The institute acts as a conduit between the academic community and research funding organizations.

Resources & Funding

The Life Sciences Innovation Fund (LSIF) is an early-stage co-investment fund that supports companies in Life Sciences and Healthcare Technologies sectors related to human health. The fund is aimed at addressing the unique challenges faced by life sciences entrepreneurs moving innovative and capital-intensive investments from a conceptual stage through to commercialization.

Apply now!

The Life Sciences Scale-Up Fund (LSSUF) supports small- to medium- sized life sciences enterprises (SMEs) to scale-up, innovate, and increase competitiveness by providing funding needed to commercialize a market ready product and prepare for procurement opportunities.

A successful applicant could receive up to $2.5 million to help cover up to 33% of eligible project costs. Successful applicants are required to secure funding to cover at least 67% of remaining eligible project costs.

Applications will be accepted starting January 20th, 2025, and will close on March 3rd, 2025.

Contact Ben McIlquham

Investment Manager,
Health Innovation
613-544-2725 x 7248
Cell: 613-532-1853
mcilquham@investkingston.ca